Lichen Teng
Papers
1
Total Citations
12
H-Index
1
About
Lichen Teng is a pioneering urological surgeon and researcher whose work focuses on advancing robotic-assisted surgery, particularly in the domains of partial nephrectomy and radical prostatectomy. His most notable contribution is leading a prospective, single-center, non-randomized clinical trial that compared the performance of two Chinese surgical systems—the KangDuo-SR-2000 and EDGE MP1000—against the globally dominant Da Vinci Xi system. This landmark 2025 study, which has already garnered 12 citations, demonstrated the feasibility and safety of domestically developed robotic platforms, marking a significant step toward reducing surgical technology dependence and lowering healthcare costs. Teng’s research directly addresses the critical need for accessible, high-precision surgical tools in urology, with implications for global surgical equity. By rigorously evaluating these emerging systems, he has provided foundational evidence that could reshape operating room standards. His work not only highlights technical innovation but also underscores the importance of clinical validation in adopting new medical technologies. For students and researchers, Teng exemplifies how comparative effectiveness research can drive meaningful change in surgical practice, bridging the gap between engineering and patient care.
Research Focus
Key Achievements
Top Papers
- 1